-transparent.png){kind=logo}
Amiodarone is an effective antiarrhythmic agent whose use is associated with several drug interactions one of which is potentiation of the action of warfarin. The mechanism of this interaction has hitherto been unclear. We examined possible mechanisms in eight patients. Total plasma warfarin clearance was found to be reduced by amiodarone. No change was detected in the binding of warfarin to plasma proteins. No relationship was found between plasma amiodarone concentrations and the change in warfarin clearance.
Related Publications
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
December 1972,
Clinical science,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
June 1987,
European journal of clinical investigation,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
September 1979,
British journal of clinical pharmacology,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
January 2002,
Psychophysiology,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
February 1977,
Il Farmaco; edizione pratica,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
April 2015,
European journal of clinical pharmacology,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
December 1986,
Archives of internal medicine,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
May 1983,
British journal of clinical pharmacology,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
November 1992,
Atherosclerosis,
A H Watt, and
M R Stephens, and
D C Buss, and
P A Routledge
April 2012,
Clinical pharmacology and therapeutics,
